BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 29221487)

  • 1. Clinical laboratory verification of thyroglobulin concentrations in the presence of autoantibodies to thyroglobulin: comparison of EIA, radioimmunoassay and LC MS/MS measurements in an Urban Hospital.
    Wheeler SE; Liu L; Blair HC; Sivak R; Longo N; Tischler J; Mulvey K; Palmer OMP
    BMC Res Notes; 2017 Dec; 10(1):725. PubMed ID: 29221487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Research on comparison of thyroglobulin autoantibody interference in measurement of thyroglobulin between electrochemiluminescent assay and radioimmunoassay].
    Dai Q; Kuang A
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Apr; 29(2):242-6. PubMed ID: 22616166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroglobulin (Tg) Testing Revisited: Tg Assays, TgAb Assays, and Correlation of Results With Clinical Outcomes.
    Netzel BC; Grebe SK; Carranza Leon BG; Castro MR; Clark PM; Hoofnagle AN; Spencer CA; Turcu AF; Algeciras-Schimnich A
    J Clin Endocrinol Metab; 2015 Aug; 100(8):E1074-83. PubMed ID: 26079778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discordance in thyroglobulin measurements by radioimmunoassay and immunometric assay: a useful means of identifying thyroglobulin assay interference.
    Crane MS; Strachan MW; Toft AD; Beckett GJ
    Ann Clin Biochem; 2013 Sep; 50(Pt 5):421-32. PubMed ID: 23847033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma.
    Spencer CA; Takeuchi M; Kazarosyan M; Wang CC; Guttler RB; Singer PA; Fatemi S; LoPresti JS; Nicoloff JT
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1121-7. PubMed ID: 9543128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroglobulin immunoassay with a fully automated pretreatment process provides accurate thyroglobulin values in anti-thyroglobulin antibody positive specimens.
    Kitamura Y; Narita S; Yagi S; Aoyagi K
    Clin Biochem; 2023 Aug; 118():110598. PubMed ID: 37330000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum thyroglobulin (Tg) monitoring of patients with differentiated thyroid cancer using sensitive (second-generation) immunometric assays can be disrupted by false-negative and false-positive serum thyroglobulin autoantibody misclassifications.
    Spencer C; Petrovic I; Fatemi S; LoPresti J
    J Clin Endocrinol Metab; 2014 Dec; 99(12):4589-99. PubMed ID: 25226290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current thyroglobulin autoantibody (TgAb) assays often fail to detect interfering TgAb that can result in the reporting of falsely low/undetectable serum Tg IMA values for patients with differentiated thyroid cancer.
    Spencer C; Petrovic I; Fatemi S
    J Clin Endocrinol Metab; 2011 May; 96(5):1283-91. PubMed ID: 21325460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical review: Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC).
    Spencer CA
    J Clin Endocrinol Metab; 2011 Dec; 96(12):3615-27. PubMed ID: 21917876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical and clinical performance of thyroglobulin autoantibody assays in thyroid cancer follow-up.
    Katrangi W; Grebe SKG; Algeciras-Schimnich A
    Clin Chem Lab Med; 2017 Oct; 55(12):1987-1994. PubMed ID: 28672730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroglobulin antibody (TgAb) methods - Strengths, pitfalls and clinical utility for monitoring TgAb-positive patients with differentiated thyroid cancer.
    Spencer C; Fatemi S
    Best Pract Res Clin Endocrinol Metab; 2013 Oct; 27(5):701-12. PubMed ID: 24094640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum thyroglobulin in the monitoring of differentiated thyroid cancer.
    Evans C; Tennant S; Perros P
    Scand J Clin Lab Invest Suppl; 2016; 245():S119-23. PubMed ID: 27542000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of Low Levels of Thyroglobulin Autoantibodies Associated with Undetectable Thyroglobulin After Thyroidectomy for Differentiated Thyroid Carcinoma.
    Latrofa F; Ricci D; Sisti E; Piaggi P; Nencetti C; Marinò M; Vitti P
    Thyroid; 2016 Jun; 26(6):798-806. PubMed ID: 27020734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocytic thyroiditis on histology correlates with serum thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: impact on detection of serum thyroglobulin.
    Latrofa F; Ricci D; Montanelli L; Rocchi R; Piaggi P; Sisti E; Grasso L; Basolo F; Ugolini C; Pinchera A; Vitti P
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2380-7. PubMed ID: 22539585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Impact of Detectable Antithyroglobulin Antibodies Below the Reference Limit (Borderline) in Patients with Papillary Thyroid Carcinoma with Undetectable Serum Thyroglobulin and Normal Neck Ultrasonography After Ablation: A Prospective Study.
    Côrtes MCS; Rosario PW; Oliveira LFF; Calsolari MR
    Thyroid; 2018 Feb; 28(2):229-235. PubMed ID: 29325506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithyroglobulin antibodies in patients with differentiated thyroid carcinoma: methods of detection, interference with serum thyroglobulin measurement and clinical significance.
    Rosário PW; Maia FF; Fagundes TA; Vasconcelos FP; Cardoso LD; Purisch S
    Arq Bras Endocrinol Metabol; 2004 Aug; 48(4):487-92. PubMed ID: 15761511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas.
    Spencer CA; Bergoglio LM; Kazarosyan M; Fatemi S; LoPresti JS
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5566-75. PubMed ID: 15985472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal?
    Mariotti S; Barbesino G; Caturegli P; Marinó M; Manetti L; Pacini F; Centoni R; Pinchera A
    J Clin Endocrinol Metab; 1995 Feb; 80(2):468-72. PubMed ID: 7852506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of serum thyroglobulin and antithyroglobulin antibody in differentiated thyroid cancer after thyroid ablation].
    Vincze B; Sinkovics I; Keresztes S; Gergye M; Boér A; Remenár E; Péter I; Szentirmay Z; Kremmer T; Kásler M
    Magy Onkol; 2004; 48(1):27-34. PubMed ID: 15105893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroglobulin (Tg) recovery testing with quantitative Tg antibody measurement for determining interference in serum Tg assays in differentiated thyroid carcinoma.
    Persoon AC; Links TP; Wilde J; Sluiter WJ; Wolffenbuttel BH; van den Ouweland JM
    Clin Chem; 2006 Jun; 52(6):1196-9. PubMed ID: 16574765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.